Evolysse

Technology

Last mentioned: Mar 19, 2026

Timeline

  1. Insider Sale

    CMO Rui Avelar sells 29,996 shares of EOLS stock.

  2. Revenue Targets Raised

    Management increases 2028 revenue goals citing market stabilization.

  3. SEC Filing Update

    Company files notice regarding changes or departures in director/officer roles.

  4. Q4 Earnings Beat

    Evolus reports record results and triggers a significant stock rally.

Stories mentioning Evolysse 1

markets Neutral

Evolus Insider Rui Avelar Sells Shares Following Record Stock Rally

Evolus Chief Medical Officer Rui Avelar sold 29,996 shares of EOLS stock on March 19, 2026, following a period of significant price appreciation. The transaction occurs as the aesthetics company raises its long-term revenue targets and reports stabilizing trends in the neurotoxin market.

2 sources